Rapid Micro Valuation

RPID Stock  USD 1.04  0.04  3.70%   
Today, the company appears to be undervalued. Rapid Micro Biosystems holds a recent Real Value of $2.25 per share. The prevailing price of the company is $1.04. Our model determines the value of Rapid Micro Biosystems from analyzing the company fundamentals such as Shares Outstanding of 37.6 M, operating margin of (1.58) %, and Return On Equity of -0.46 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
1.04
Please note that Rapid Micro's price fluctuation is risky at this time. Calculation of the real value of Rapid Micro Biosystems is based on 3 months time horizon. Increasing Rapid Micro's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Rapid stock is determined by what a typical buyer is willing to pay for full or partial control of Rapid Micro Biosystems. Since Rapid Micro is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Rapid Stock. However, Rapid Micro's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.04 Real  2.25 Hype  1.04
The real value of Rapid Stock, also known as its intrinsic value, is the underlying worth of Rapid Micro Biosystems Company, which is reflected in its stock price. It is based on Rapid Micro's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Rapid Micro's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
2.25
Real Value
5.46
Upside
Estimating the potential upside or downside of Rapid Micro Biosystems helps investors to forecast how Rapid stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rapid Micro more accurately as focusing exclusively on Rapid Micro's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.051.044.25
Details

Rapid Micro Total Value Analysis

Rapid Micro Biosystems is at this time forecasted to have valuation of (3.6 M) with market capitalization of 50.78 M, debt of 7.35 M, and cash on hands of 145.1 M. The negative valuation of Rapid Micro may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Rapid Micro fundamentals.
  Takeover PriceMarket CapDebt ObligationsCash
(3.6 M)
50.78 M
7.35 M
145.1 M

Rapid Micro Investor Information

About 59.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.6. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Rapid Micro Biosystems recorded a loss per share of 1.12. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 29th of October 2010. Based on the analysis of Rapid Micro's profitability, liquidity, and operating efficiency, Rapid Micro Biosystems is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.

Rapid Micro Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Rapid Micro has an asset utilization ratio of 15.7 percent. This indicates that the Company is making $0.16 for each dollar of assets. An increasing asset utilization means that Rapid Micro Biosystems is more efficient with each dollar of assets it utilizes for everyday operations.

Rapid Micro Ownership Allocation

Rapid Micro owns a total of 37.6 Million outstanding shares. Over half of Rapid Micro's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Rapid Micro Profitability Analysis

The company reported the previous year's revenue of 22.52 M. Net Loss for the year was (52.47 M) with loss before overhead, payroll, taxes, and interest of (8.54 M).
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Rapid Micro's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Rapid Micro and how it compares across the competition.

About Rapid Micro Valuation

The stock valuation mechanism determines Rapid Micro's current worth on a weekly basis. Our valuation model uses a comparative analysis of Rapid Micro. We calculate exposure to Rapid Micro's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Rapid Micro's related companies.
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts. Rapid Micro operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 202 people.

Rapid Micro Growth Indicators

Investing in growth stocks can be very risky. If the company such as Rapid Micro does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding43 M

Complementary Tools for Rapid Stock analysis

When running Rapid Micro's price analysis, check to measure Rapid Micro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rapid Micro is operating at the current time. Most of Rapid Micro's value examination focuses on studying past and present price action to predict the probability of Rapid Micro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rapid Micro's price. Additionally, you may evaluate how the addition of Rapid Micro to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios